chr5-90745694-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032119.4(ADGRV1):āc.10873C>Gā(p.Leu3625Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,611,834 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.10873C>G | p.Leu3625Val | missense_variant | 52/90 | ENST00000405460.9 | NP_115495.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.10873C>G | p.Leu3625Val | missense_variant | 52/90 | 1 | NM_032119.4 | ENSP00000384582 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000885 AC: 22AN: 248586Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 134890
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1459726Hom.: 1 Cov.: 29 AF XY: 0.0000633 AC XY: 46AN XY: 726288
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74292
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 28, 2023 | Identified in an individual with Usher syndrome who either had an alternate molecular explanation for disease or in whose family the variant did not segregate with disease (Le-Quesne Stabej et al., 2012); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22135276) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 03, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 24, 2019 | Variant classified as Uncertain Significance - Favor Benign. The p.Leu3625Val variant in ADGRV1 has been reported in the homozygous state in 1 individual with Ushers syndrome type 2 (Le Quesne Stabej 2012) and has also been identified in 0.06% (21/30592) South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). In addition, it has now been detected by our laboratory in cis with another pathogenic variant in the ADGRV1 gene in two individuals, which suggests that this variant is less likely to be pathogenic. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Leu3625Val variant is uncertain. In summary, while the clinical significance of the p.Leu3625Val variant is uncertain, its presence in cis with another pathogenic ADGRV1 variant suggests that it is more likely to be benign. ACMG/AMP Criteria applied: BP2; PP3. - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Sep 21, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at